Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod versus placebo in chronic inflammatory demyelinating polyradiculoneuropathy
2011-005280-24Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic inflammatory demyelinating polyneuropathy (CIDP) comparing Fingolimod with Placebo (2 arms). Primary endpoint: Time to first confirmed worsening on adjusted INCAT disability scale. Started Jul 2012; status: completed.
02
Drugs
fingolimod
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2011-005280-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005280-24.